Cancers (Jan 2023)

3q26.2/<i>MECOM</i> Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic Features

  • Zhenya Tang,
  • Wei Wang,
  • Su Yang,
  • Hanadi El Achi,
  • Hong Fang,
  • Karen Amelia Nahmod,
  • Gokce A. Toruner,
  • Jie Xu,
  • Beenu Thakral,
  • Edward Ayoub,
  • Ghayas C. Issa,
  • C. Cameron Yin,
  • M. James You,
  • Roberto N. Miranda,
  • Joseph D. Khoury,
  • L. Jeffrey Medeiros,
  • Guilin Tang

DOI
https://doi.org/10.3390/cancers15020458
Journal volume & issue
Vol. 15, no. 2
p. 458

Abstract

Read online

MECOM rearrangement (MECOM-R) resulting from 3q26.2 aberrations is often associated with myeloid neoplasms and inferior prognosis in affected patients. Uncommonly, certain 3q26.2/MECOM-R can be subtle/cryptic and consequently overlooked by karyotyping. We identified 17 acute myeloid leukemia (AML) patients (male/female: 13/4 with a median age of 67 years, range 42 to 85 years) with a pericentric inv(3) leading to MECOM-R, with breakpoints at 3p23 (n = 11), 3p25 (n = 3), 3p21 (n = 2) and 3p13 (n = 1) on 3p and 3q26.2 on 3q. These pericentric inv(3)s were overlooked by karyotyping initially in 16 of 17 cases and later detected by metaphase FISH analysis. Similar to the patients with classic/paracentric inv(3)(q21q26.2), patients with pericentric inv(3) exhibited frequent cytopenia, morphological dysplasia (especially megakaryocytes), −7/del(7q), frequent NRAS (n = 6), RUNX1 (n = 5) and FLT-3 (n = 4) mutations and dismal outcomes (median overall survival: 14 months). However, patients with pericentric inv(3) more frequently had AML with thrombocytopenia (n = 15, 88%), relative monocytosis in peripheral blood (n = 15, 88%), decreased megakaryocytes (n = 11, 65%), and lower SF3B1 mutation. We conclude that AML with pericentric inv(3) shares some similarities with AML associated with classic/paracentric inv(3)/GATA2::MECOM but also shows certain unique features. Pericentric inv(3)s are often subtle/cryptic by chromosomal analysis. A reflex FISH analysis for MECOM-R is recommended in myeloid neoplasms showing −7/del(7q).

Keywords